常见消毒液对生物膜中临床相关微生物的疗效
本研究通过体外 drip-flow reactor 模型,测试多种消毒液对 nascent(4小时)和 mature(3天)单菌种生物膜的疗效。结果显示聚维酮碘对 nascent MRSA 生物膜 log 减少值最大(LR=3.12, p<0.001),Bactisure 对 mature 铜绿假单胞菌(LR=1.94, p=0.032)和 mature 表皮葡萄球菌(LR=2.12, p=0.025)减少最大。汇总数据表明 Bactisure 和聚维酮碘显著优于 Vashe、Prontosan 和 Irrisept(p<0.001)。
要点
- 聚维酮碘对 nascent MRSA 生物膜减少最大(LR=3.12, p<0.001)。
- Bactisure 对 mature 铜绿假单胞菌和表皮葡萄球菌减少最大。
- 汇总数据中 Bactisure 和聚维酮碘显著优于 Vashe、Prontosan、Irrisept。
核心结论
- 不同消毒液对生物膜中临床相关微生物的体外疗效存在显著差异。
- 需进一步临床结局数据确定这些溶液能否影响体内 PJI 结局。
研究设计与样本
- 体外研究,使用 drip-flow reactor 模型测试消毒液对 nascent(4小时)和 mature(3天)单菌种生物膜的疗效。
主要发现
- 聚维酮碘对 nascent MRSA 生物膜 log 减少值(LR=3.12)大于其他溶液(p<0.001)。
- Bactisure 对 mature 铜绿假单胞菌生物膜减少最大(LR=1.94, p=0.032)。
- Bactisure 对 mature 表皮葡萄球菌生物膜减少大于 Vashe 或 Irrisept(LR=2.12, p=0.025)。
- 汇总所有测试生物膜数据,Bactisure 和聚维酮碘的减少显著大于 Vashe、Prontosan 和 Irrisept(p<0.001)。
关键数值与推荐
- nascent MRSA 生物膜:聚维酮碘 LR=3.12, p<0.001。
- mature 铜绿假单胞菌生物膜:Bactisure LR=1.94, p=0.032。
- mature 表皮葡萄球菌生物膜:Bactisure LR=2.12, p=0.025。
- 汇总生物膜数据:Bactisure 和聚维酮碘 vs Vashe、Prontosan、Irrisept,p<0.001。
临床怎么用
- 消毒液可作为 PJI 生物膜清除的辅助手段,但需结合临床结局数据选择。
局限性
- 本研究为体外研究,需进一步临床结局数据确定体内效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Periprosthetic joint infections (PJIs) are among the most devastating complications after joint arthroplasty. There is limited evidence on the efficacy of different antiseptic solutions on reducing biofilm burden. The purpose of the present study was to test the efficacy of different antiseptic solutions against clinically relevant microorganisms in biofilm. METHODS: We conducted an in vitro study examining the efficacy of several antiseptic solutions against clinically relevant microorganisms. We tested antiseptic irrigants against nascent (four-hour) and mature (three-day) single-species biofilm created in vitro using a drip-flow reactor model. RESULTS: With regard to irrigant efficacy against biofilms, Povidone-iodine treatment resulted in greater reductions in nascent MRSA biofilms (logarithmic reduction (LR) = 3.12; p < 0.001) compared to other solutions. Bactisure treatment had the greatest reduction of mature Pseudomonas aeruginosa biofilms (LR = 1.94; p = 0.032) and a larger reduction than Vashe or Irrisept for mature Staphylococcus epidermidis biofilms (LR = 2.12; p = 0.025). Pooled data for all biofilms tested resulted in Bactisure and Povidone-iodine with significantly greater reductions compared to Vashe, Prontosan, and Irrisept solutions (p < 0.001). CONCLUSION: Treatment failure in PJI is often due to failure to clear the biofilm; antiseptics are often used as an adjunct to biofilm clearance. We tested irrigants against clinically relevant microorganisms in biofilm in vitro and showed significant differences in efficacy among the different solutions. Further clinical outcome data is necessary to determine whether these solutions can impact PJI outcome in vivo. Cite this article: Bone Joint J 2021;103-B(5):908-915.
引用
- O'Donnell JA, Wu M, Cochrane NH, et al. Efficacy of common antiseptic solutions against clinically relevant microorganisms in biofilm. Bone Joint J. 2021. PMID: 33934664. doi:10.1302/0301-620X.103B5.BJJ-2020-1245.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。